IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 275, Issue 1 38-1, 1998, Pages

  Kuemmerle, John F ^a   Bushman, Toni L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LY 294002; P85; PD 98059; Phosphatidylinositol 3,4,5 triphosphate; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; THYMIDINE; TRITIUM;

ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE MUSCLE; JEJUNUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0031831089     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.275.1.g151     Document Type: Article

References (46)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494, 1995.
2. Baserga, R., C. Sell, P. Porcu, and M. Rubini. The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif. 27: 63-71, 1994.
3. Cambrey, A. D., O. J. Kwon, A. J. Gray, N. K. Harrison, M. Yacoub, P. J. Barnes, G. J. Laurent, and K. F. Chung. Insulin-like growth factor I is a major fibroblast mitogen produced by primary cultures of human airway epithelial cells. Clin. Sci. 89: 611-617, 1995.
4. Chen, Y., A. Arner, K. E. Bornfeldt, B. Uvelius, and H. J. Arnqvist. Development of smooth muscle hypertrophy is closely associated with increased gene expression of insulin-like growth factor binding protein-2 and -4. Growth Regul. 5: 45-52, 1995.
5. Chen, Y., K. E. Bornfeldt, A. Arner, E. Jennische, W. Malmqvist, B. Uvelius, and H. J. Arnqvist. Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E224-E229, 1994.
6. Coolican, S. A., F. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272: 6653-6662, 1997.
7. Dardevet, D., C. Sornet, T. Vary, and J. Grizzard. Phosphatidylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 137: 4087-4094, 1996.
8. Dempsey, E. C., D. B. Badesch, E. L. Dobyna, and K. R. Stenmark. Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: dependence on cell size, time from birth, insulin-like growth factor I and auto-activation of protein kinase C. J. Cell. Physiol. 160: 469-481, 1994.
9. Engert, J. C., E. B. Berglund, and N. Rosenthal. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 135: 431-440, 1996.
10. Ettinger, S. L., R. W. Lauener, and V. Durinio. Protein kinase δ specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation. J. Biol. Chem. 271: 14514-14518, 1996.
11. Foncea, R., M. Andersson, A. Ketterman, V. Blakesley, M. Sapag-Hagart, P. H. Sugden, D. LeRoith, and S. Lavender. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J. Biol. Chem. 272: 19115-19124, 1997.
12. Higaki, M., H. Sakaue, W. Ogawa, M. Kasuga, and K. Shimokodo. Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J. Biol. Chem. 271: 29342-29346, 1996.
13. Kongo, A., C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12: 1231-1238, 1996.
14. Kamai, Y., S. Mikawa, K. Endo, H. Sakai, and T. Komano. Regulation of insulin-like growth factor-I expression in mouse preadipocyte Ob1771 cells. J. Biol. Chem. 271: 9883-9886, 1996.
15. Kuemmerle, J. F. Autocrine regulation of growth in cultured human intestinal muscle by growth-factors. Gastroenterology 111: 817-824, 1997.
16. Laburthe, M., C. Rouyer-Fessard, and S. Gammeltoft. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am. J. Physiol. 254 (Gastrointest. Liver Physiol. 17): G457-G462, 1988.
17. Lemmey, A. B., A. A. Martin, L. C. Read, R. M. Tomas, P. C. Owens, and F. J. Ballard. IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E213-E219, 1991.
18. Li, S., M. Resnicoff, and R. Baserga. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271: 12254-12260, 1996.
19. Myers, M. G., X. J. Sun, B. Cheatham, B. R. Jachna, E. M. Glasheen, J. M. Backer, and M. F. White. IRS-1 is a common element in insulin and insulin-like growth factor signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132: 1421-1430, 1993.
20. Nakanishi, H., K. Brewer, and J. H. Exton. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 268: 13-16, 1993.
21. Noveral, J. P., A. Bhala, R. L. Hintz, M. M. Gruenstein, and P. Cohen. Insulin-like growth factor axis in pulmonary smooth muscle cells. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L761-L765, 1994.
22. O'Connor, R., A. Kauffmann-Zeh, W. Liu, S. Lehar, G. I. Evan, R. Baserga, and W. A. Blattler. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17: 427-435, 1997.
23. Ohneda, K., M. H. Ulshen, C. R. Fuller, A. J. D'Ercole, and P. K. Lund. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112: 444-454, 1997.
24. Párrizas, M., A. R. Saltiel, and D. LeRoith. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272: 154-161, 1997.
25. Rao, G. N., P. Delafontaine, and M. S. Runge. Thrombin stimulates phosphorylation of insulin-like growth factor-I receptor, insulin receptor substrate-1, and phospholipase C-γ1 in rat aortic smooth muscle cells. J. Biol. Chem. 270: 27871-27875, 1995.
26. Reape, T. J., J. M. Kanczler, J. P. T. Ward, and C. R. Thomas. IGF-I increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cells. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1141-H1148, 1996.
27. Rodriguez, V. P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. Phosphatidylinositol-3-OH kinase as a direct target of ras. Nature 370: 527-532, 1994.
28. Rosenthal, S. M., and Z.-Q. Cheng. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 10307-10311, 1995.
29. Sasaoka, T., M. Ishiki, T. Sawa, H. Ishihara, Y. Takata, T. Imamura, I. Usui, J. M. Olefshy, and M. Kobayashi. Comparison of the insulin and insulin-like growth factor I mitogenic intracellular signaling pathways. Endocrinology 137: 4427-4434, 1996.
30. Sasaoka, T., D. W. Rose, B. H. Jhun, A. R. Saltiel, B. Draznin, and J. M. Olefsky. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-I, and epidermal growth factor. J. Biol. Chem. 269: 13689-13694, 1994.
31. Sell, C., M. Rubini, R. Rubin, J.-P. Liu, A. Efstatriadis, and R. Baserga. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90: 11217-11221, 1993.
32. Tartare-Deckert, S., J. Murdaca, D. Sawka-Verhelle, K. H. Holt, J. E. Pessin, and E. Van Obberghen. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and insulin-like growth factor-I (IGF-I) receptor: comparative study using the yeast two-hybrid system. Endocrinology 137: 1019-1024, 1996.
33. Termanini, B., R. V. Nardi, T. M. Finan, I. Parikh, and L. Y. Korman. Insulin-like growth factor I receptors in rabbit gastrointestinal tract. Characterization and autoradiographic localization. Gastroenterology 99: 51-60, 1990.
34. Thommes, K. B., J. Hoppe, H. Vetter, and A. Sachinidis. The synergistic effect of PDGF-AA and IGF-I on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways. Exp. Cell Res. 226: 59-66, 1996.
35. Toker, A., and L. C. Cantley. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673-676, 1997.
36. Valverde, A. M., T. Teruel, M. Lorenzo, and M. Benito. Involvement of raf-1 kinase and protein kinase C in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3′,5′-monophosphate. Endocrinology 137: 2832-3841, 1996.
37. Van der Ven, L. T., S. C. Van Buul-Offers, T. Gloudemans, R. J. Bloemen, P. J. Roholl, J. S. Sussenbach, and W. Den Otter. Modulation of insulin-like growth factor (IGF) action by IGF-binding proteins in normal, benign, and malignant smooth muscle tissues. J. Clin. Endocrinol. Metab. 81: 3629-3635, 1996.
38. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269: 5241-5248, 1994.
39. Wu, Y., M. Tewari, S. Cui, and R. Rubin. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J. Cell. Physiol. 168: 499-509, 1996.
40. Yamamoto, M., and K. Yamamoto. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor. Exp. Cell Res. 212: 62-68, 1994.
41. Yamauchi, K., K. Holt, and J. E. Pessin. Phosphatidylinositol 3-kinase functions upstream of ras and raf in mediating insulin stimulation of c-fos and transcription. J. Biol. Chem. 268: 14597-14600, 1993.
42. Young, G. P., T. M. Taranto, H. A. Jones, A. J. Cox, A. Hogg, and G. A. Werther. Insulin-like growth factors and the developing and mature rat small intestine: receptors and biological actions. Digestion 46 (Suppl. 2): 240-252, 1990.
43. Yuan, Q. X., J. A. McRoberts, J. Lakshmanan. H. Yagi, and P. E. Hyman. Newborn rabbit gastric smooth muscle cell culture: EGF and TGF-α are potent mitogens. J. Pediatr. Gastroenteral. Nutr. 17: 153-160, 1993.
44. Zeeh, J. M., P. Hoffmann, M. Sottili, V. E. Eysselein, and J. A. McRoberts. Up-regulation of insulin-like growth factor I binding sites in experimental colitis in rats. Gastroenterology 108: 644-652, 1995.
45. Zimmermann, E. M., L. Li, Y. T. Hou, M. Cannon, G. M. Christman, and K. N. Bitar. IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am. J. Physiol. 273 (Gastrointest. Liver Physiol. 36): G875-G882, 1997.
46. Zimmermann, E. M., R. B. Sartor, R. D. McCall, M. Pardo, D. Bender, and P. K. Lund. Insulin-like growth factor I and interleukin 1 messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 105: 399-409, 1993.